Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|August 31, 2024
All-magnonic repeater based on bistabilityQi Wang, Roman Verba, Kristýna Davídková, et al.Nature Communications|September 27, 2024
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trialDalong Zhu, Weimin Wang, Guoyu Tong, et al.The Lancet. Diabetes & Endocrinology|June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLinong Ji, Leili Gao, Haibo Xue, et al.The Lancet. Diabetes & Endocrinology|August 25, 2025
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trialYang He, Nianrong Mi, Zhifeng Cheng, et al.Nature Communications|January 7, 2026
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trialDalong Zhu, Weimin Wang, Guoyu Tong, et al.Pageof 2